Company Overview of Medicago Inc.
Medicago Inc., a clinical-stage biotechnology company, develops novel vaccines and therapeutic proteins to treat various infectious diseases worldwide. The company develops its vaccines based on its proprietary technologies comprising the plant-based Proficia technology and Virus-Like Particles (VLP) technology. Its product candidates include H5N1 pandemic influenza VLP vaccine, which has completed a Phase II human clinical trial; and seasonal influenza and H1N1 vaccines. The company’s products under development also comprise non-influenza VLP and rabies vaccine candidates. It has a strategic alliance with Mitsubishi Tanabe Pharma Corporation to develop a Rotavirus vaccine candidate; and res...
1020 Route de l'Église
Quebec, QC G1V 3V9
Founded in 1997
Key Executives for Medicago Inc.
Executive Vice President of Operations
Director of Investor Relations & Communications
Compensation as of Fiscal Year 2014.
Medicago Inc. Key Developments
Medicago Inc. Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2013
Aug 9 13
Medicago Inc. announced financial results for the second quarter and six months ended June 30, 2013. For the quarter, the company reported revenues of $918,000. Net loss was $9,073,000 or $0.04 per basic and diluted share compared to a net loss of $8,099,000 or $0.04 per basic and diluted share for the same period a year ago.
For the six-months, the company reported revenues of $1,337,000. Net loss was $17,789,000 or $0.07 per basic and diluted share compared to $17,087,000 or $0.07 per basic and diluted share for the same period a year ago.
Medicago Inc. to Report Q2, 2013 Results on Aug 09, 2013
Aug 6 13
Medicago Inc. announced that they will report Q2, 2013 results After-Market on Aug 09, 2013
Medicago Inc., Special/Extraordinary Shareholders Meeting, Aug 29, 2013
Jul 16 13
Medicago Inc., Special/Extraordinary Shareholders Meeting, Aug 29, 2013., at 11:00 Eastern Daylight. Location: McCarthy Tétrault LLP's office located at 1000. Agenda: To discuss plan of arrangement involving Mitsubishi Tanabe Pharma Corporation.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|